• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGENT?; DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGENT?; DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER Back to Search Results
Model Number H7493960815350
Medical Device Problem Codes Break (1069); Difficult to Advance (2920); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/02/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a shaft break occurred.An agent us mr 3.50 x 15mm was selected for treatment of the target lesion, which was located in the proximal circumflex.Following ivus, the physician began attempting to advance the agent balloon.It was noted that there was difficulty advancing the balloon.When attempting to properly position the balloon, the proximal end of the device broke, just before the balloon.The physician was able to completely remove the agent from the patient, and another similar device was used to successfully complete the procedure.There were no patient complications.
 
Event or Problem Description
It was reported that a shaft break occurred.An agent us mr 3.50 x 15mm was selected for treatment of the target lesion, which was located in the proximal circumflex.Following ivus, the physician began attempting to advance the agent balloon.It was noted that there was difficulty advancing the balloon.When attempting to properly position the balloon, the proximal end of the device broke, just before the balloon.The physician was able to completely remove the agent from the patient, and another similar device was used to successfully complete the procedure.There were no patient complications.
 
Additional Manufacturer Narrative
The returned product consisted of the agent balloon and catheter.A visual examination of the device revealed a break 18cm distal to the end of the strain relief with multiple kinks along the hypotube shaft.There were no other damages or defects discovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGENT?
Common Device Name
DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key22395731
Report Number2124215-2025-43191
Device Sequence Number14677786
Product Code OOB
UDI-Device Identifier00191506014766
UDI-Public(01)00191506014766(17)260411(10)3465H24
Combination Product (Y/N)Y
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P230035
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/25/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/11/2026
Device Model NumberH7493960815350
Device Catalogue NumberH7493960815350
Device Lot Number03465H24
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/17/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/02/2025
Supplement Date Received by Manufacturer07/29/2025
Initial Report FDA Received Date07/03/2025
Supplement Report FDA Received Date08/25/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/11/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-